Survival and Biomarkers of COVID-19 Patients Treated with Remdesivir and Favipiravir in ICU during the Peak of Pandemic: A Single Center Study in Bangladesh
M. Nasir, R. A. Perveen, M. Murshed, R. Nazneen & K. A. Talha · Journal of Pharmaceutical Research International · 2021
Since the first detection of a cluster of COVID-19 patients in China in late 2019, it becomes a global concern due to its transmissibility and ability to progress patients in severe respiratory failure and acute respiratory distress syndrome, which need intensive care unit suppor...
Open access
Research Article
10.9734/jpri/2020/v32i4531088